S100A9 and coronary aneurysm: Notably, research into IVIG treatment for KD has revealed elevated levels of S100A8 and S100A9 in the serum of KD patients during the acute phase, with a subsequent decline in levels post-treatment, except in cases where patients developed coronary aneurysms.